Pathophysiology of Acute Lymphoblastic Leukemia

  • P. M
  • Borjas-Gutierrez C
  • M. G
  • et al.
N/ACitations
Citations of this article
23Readers
Mendeley users who have this article in their library.

Abstract

The Acute lymphoblastic leukemia (ALL), it produced as a result of a process of malignant transformation of a progenitor lymphocytic cell in the B and T lineages. In ALL, the majority of the cases, the transformation affects the B lineage cells. Leukemia and other cancers share biological characteristics, as clonality. The molecular alterations that are required for the de‐ velopment of a malignant disease is a rare phenomenon when one considers the large number of target cells susceptible to this condition, in other words, a single genetic change rarely be sufficient for developing a malignant tumor. This means that a small percentage of people (1%) who develop malignant hematological disease, probably only 1 cell mutated in a critical gene for the proliferation, differentiation and survival of progenitor cells. There is evidence sup‐ porting a sequential multistep process, of alterations in several oncogenes in tumor suppressor genes or microRNA genes in cancerigen cells.

Cite

CITATION STYLE

APA

P., M., Borjas-Gutierrez, C., M., G., E., L., M., A., & R., J. (2013). Pathophysiology of Acute Lymphoblastic Leukemia. In Clinical Epidemiology of Acute Lymphoblastic Leukemia - From the Molecules to the Clinic. InTech. https://doi.org/10.5772/54652

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free